ATE370962T1 - Entfernung von prionen durch den gebrauch von metalloxid partikeln - Google Patents

Entfernung von prionen durch den gebrauch von metalloxid partikeln

Info

Publication number
ATE370962T1
ATE370962T1 AT04783316T AT04783316T ATE370962T1 AT E370962 T1 ATE370962 T1 AT E370962T1 AT 04783316 T AT04783316 T AT 04783316T AT 04783316 T AT04783316 T AT 04783316T AT E370962 T1 ATE370962 T1 AT E370962T1
Authority
AT
Austria
Prior art keywords
metal oxide
biological material
prions
removal
oxide particles
Prior art date
Application number
AT04783316T
Other languages
English (en)
Inventor
Christopher Stenland
Jarrett Terry
Jeffrey Yuziuk
Original Assignee
Bayer Healthcare Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Llc filed Critical Bayer Healthcare Llc
Application granted granted Critical
Publication of ATE370962T1 publication Critical patent/ATE370962T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Water Supply & Treatment (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Oxygen, Ozone, And Oxides In General (AREA)
  • Silicon Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT04783316T 2003-09-10 2004-09-07 Entfernung von prionen durch den gebrauch von metalloxid partikeln ATE370962T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/659,789 US20050054003A1 (en) 2003-09-10 2003-09-10 Prion clearance using particulate metal oxides

Publications (1)

Publication Number Publication Date
ATE370962T1 true ATE370962T1 (de) 2007-09-15

Family

ID=34227009

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04783316T ATE370962T1 (de) 2003-09-10 2004-09-07 Entfernung von prionen durch den gebrauch von metalloxid partikeln

Country Status (13)

Country Link
US (1) US20050054003A1 (de)
EP (1) EP1664087B1 (de)
JP (1) JP2007527405A (de)
AT (1) ATE370962T1 (de)
AU (1) AU2004272591A1 (de)
CA (1) CA2538288A1 (de)
CY (1) CY1107791T1 (de)
DE (1) DE602004008488T2 (de)
DK (1) DK1664087T3 (de)
ES (1) ES2291947T3 (de)
PL (1) PL1664087T3 (de)
PT (1) PT1664087E (de)
WO (1) WO2005026197A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4769925B2 (ja) * 2006-03-15 2011-09-07 国立大学法人東北大学 異常型プリオン蛋白質の濃縮方法、および除去方法
US8796430B2 (en) 2010-05-26 2014-08-05 Baxter International Inc. Method to produce an immunoglobulin preparation with improved yield
US8772462B2 (en) 2010-05-26 2014-07-08 Baxter International Inc. Removal of serine proteases by treatment with finely divided silicon dioxide
AU2010202125B1 (en) 2010-05-26 2010-09-02 Takeda Pharmaceutical Company Limited A method to produce an immunoglobulin preparation with improved yield
JP6664714B2 (ja) * 2016-05-09 2020-03-13 株式会社理研テクノシステム 異常型プリオンタンパク質の感染力低減方法及びプリオン病の予防治療用医薬組成物

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2390074A (en) * 1942-02-09 1945-12-04 Research Corp Protein product and process
US3998946A (en) * 1975-04-23 1976-12-21 The Regents Of The University Of Minnesota Fibrinogen-free plasminogen-plasmin-free plasma and method of preparing and using same
IL89123A (en) * 1989-01-31 1993-08-18 Ilana Tamir Method for determination of ldl-cholesterol
US5085784A (en) * 1989-04-07 1992-02-04 Cuno, Incorporated Use of cationic charge modified filter media
US5290703A (en) * 1992-12-14 1994-03-01 Miles, Inc. Method for the separation of high density lipoprotein from blood samples
BR9709900A (pt) * 1996-05-29 2000-01-25 Univ Mcgill Proteìnas de ligacão de proteìnas de prìons e usos das mesmas.
US5808011A (en) * 1996-07-01 1998-09-15 Biopure Corporation Method for chromatographic removal of prions
US6221614B1 (en) * 1997-02-21 2001-04-24 The Regents Of The University Of California Removal of prions from blood, plasma and other liquids
US6150172A (en) * 1999-01-08 2000-11-21 The United States Of America As Represented By The Secretary Of Agriculture Method and kit for extracting prion protein
AU5778400A (en) * 1999-06-29 2001-01-31 Caprion Pharmaceuticals, Inc. Prion protein binding proteins and uses thereof
US7544500B2 (en) * 1999-11-13 2009-06-09 Talecris Biotherapeutics, Inc. Process for the production of a reversibly inactive acidified plasmin composition
US6437102B1 (en) * 1999-11-24 2002-08-20 Bayer Corporation Method of separating prions from biological materials
EP1386159A2 (de) * 2001-01-16 2004-02-04 Biotransplant, Inc Verwendung von mikropartikeln mit hoher dichte zur entfernung von pathogenen
EP1385871B1 (de) * 2001-05-08 2006-04-19 Serologicals Investment Company, Inc. Verfahren zur inaktivierung von prionen in lipoproteinen
ATE325655T1 (de) * 2001-06-22 2006-06-15 Argonide Corp Submikron filter
JP4783727B2 (ja) * 2003-04-04 2011-09-28 パソゲン リムーバル アンド ダイアグノスティック テクノロジーズ インコーポレーテッド プリオンタンパク質結合物質と使用法

Also Published As

Publication number Publication date
PT1664087E (pt) 2007-11-09
JP2007527405A (ja) 2007-09-27
US20050054003A1 (en) 2005-03-10
PL1664087T3 (pl) 2008-06-30
WO2005026197A1 (en) 2005-03-24
CY1107791T1 (el) 2013-06-19
DK1664087T3 (da) 2007-12-27
DE602004008488T2 (de) 2008-01-03
EP1664087B1 (de) 2007-08-22
AU2004272591A1 (en) 2005-03-24
DE602004008488D1 (de) 2007-10-04
EP1664087A1 (de) 2006-06-07
ES2291947T3 (es) 2008-03-01
CA2538288A1 (en) 2005-03-24

Similar Documents

Publication Publication Date Title
ATE437222T1 (de) Alphavirus replikon-vektorsysteme
ATE382053T1 (de) System zur antikörperexpression und- synthese
ATE483472T1 (de) Cd16a bindungsproteine und verwendung zur behandlung von immunkrankheiten
AU3947801A (en) Hybrid expression of neisserial proteins
PL371736A1 (en) Method for administering glp-1 molecules
DK1321477T3 (da) Fremgangsmåde til frembringelsen af genetisk modificerede vertebrate precursor-lymfocytter og anvendelse deraf til fremstillingen af heterologe bindende proteiner
SI1644484T1 (sl) Avtologne samo-toleranco inducirajoče celice monocitnega izvora in njihova uporaba v farmacevtskihpripravah
DE502005004912D1 (de) Reinigung von ionischen flüssigkeiten
ATE442869T1 (de) Suspension zur verminderung von geruch
GB0216001D0 (en) Process and composition
ATE496892T1 (de) Tetrahydroisochinolinverbindungen zur behandlung von zns-erkrankungen
DE10193689D2 (de) Retardpartikeldispersion
ATE430160T1 (de) Lipopeptid-stereoisomere, verfahren zu ihrer herstellung und nützliche zwischenprodukte
ATE267770T1 (de) Reaktor zur herstellung von hochreinem, granularem silizium
NO20055741L (no) Nye kjemiske forbindelser
DE60330921D1 (de) Verfahren zur Herstellung von modifiziertem Zinnoxidsol und Zinnoxid-Zirkonoxid-Mischsol.
ATE370962T1 (de) Entfernung von prionen durch den gebrauch von metalloxid partikeln
ATE421339T1 (de) Vereinfachte methode zur entfernung von freiem protein während der herstellung von protein- polysaccharid-konjugaten und impfstoffen unter verwendung von medien mit limitierter durchlässigkeit
EP1534404A4 (de) Verwendung eines clathratmodifizierers zur forderung des durchgangs von proteinen bei nanofiltration
AU2003251729A1 (en) Use of antibodies against flt-1 for the treatment of osteoporosis
EA200600693A1 (ru) Пакующие клетки для рекомбинантных аденовирусов
ATE487489T1 (de) Rekombinante intrazellulärepathogen-immunogene zusammensetzungen und anwendungsverfahren
DE60332076D1 (de) Doppelmessverfahren zur Anzeige des Inhalts von Poststücken
AU2003259750A8 (en) Methods and compositions for targeting secretory lysosomes
TR200503397T1 (tr) Levetirasetam'ın yeni kristal formları.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1664087

Country of ref document: EP